034940.KQ

ChoA Pharmaceutical Co., LTD.
KOSDAQKRWEQUITY DELAYED
Last price
550.00
■ 0.00 (0.00%)
MARKET ·

Price

1D H L Range Vol
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
Prev close
550.00
Day high
550.00
Day low
550.00
Volume
Market cap
P/E (TTM)
52W range
497.00 – 1,420.00

Trailing performance

Price return · vs SPY
Returnvs SPY
1W
0.00% +1.2%
1M
-9.24% -12.6%
3M
-31.51% -33.9%
6M
-43.93% -55.8%
YTD
-45.54% -57.5%
1Y
-47.87% -68.0%
3Y
-73.17% -148.2%
5Y

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Free account

3 more panels on 034940.KQ open with an account.

Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.

Fundamentals

TTM · reported
Market cap
Enterprise value
Revenue (TTM)
Gross profit
EBITDA
Net income
EPS (TTM)
Free cash flow
Total cash
Total debt
Book value / share
Shares outstanding
Float
Short % of float
Dividend yield
Beta (5Y)

Valuation & profitability ratios

Account required
Trailing P/E
Forward P/E
PEG ratio
Price / sales
Price / book
EV / revenue
EV / EBITDA
Gross margin
Operating margin
Profit margin
Return on equity
Return on assets
Debt / equity
Current ratio
Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Financial statements

As reported · 4 years · 6 quarters
Blank means not reported, not zero
Line item2025202420232022YoY
Total revenue $59.31B$62.69B$62.97B$68.88B -5.4%
Operating revenue $59.31B$62.69B$62.97B$68.88B -5.4%
Cost of revenue $37.44B$41.50B$39.21B$42.64B -9.8%
Gross profit $21.87B$21.20B$23.76B$26.24B +3.2%
Research & development $1.16B$1.56B$2.18B$1.30B -25.5%
Selling, general & admin $8.88B$10.35B$9.47B$7.67B -14.2%
Total operating expense $28.47B$30.83B$30.60B$26.72B -7.7%
Operating income -$6.60B-$9.64B-$6.83B-$482.21M +31.5%
Net interest income -$964.08M-$790.73M-$732.48M-$461.19M -21.9%
Pre-tax income -$6.42B-$10.03B-$10.93B-$424.38M +36.0%
Tax provision $939.65M$136.83M$198.70M-$939.63M +586.7%
Net income -$6.81B-$9.60B-$10.51B$560.69M +29.1%
Net income to common -$6.81B-$9.60B-$10.51B$560.69M +29.1%
Basic EPS -220.00-310.00-339.0018.00 +29.0%
Diluted EPS -220.00-310.00-339.0018.00 +29.0%
EBIT -$5.23B-$8.92B-$9.95B$252.06M +41.3%
EBITDA -$2.80B-$6.53B-$7.57B$2.64B +57.1%
Basic shares 30.94M30.98M31.02M31.15M -0.2%
Diluted shares 30.94M30.98M31.02M31.15M -0.2%

Analyst targets & ownership

Account required
Mean target
High target
Low target
Implied upside
Analyst count
Consensus
Strong buy / Buy— / —
Hold
Sell / Strong sell— / —
Held by insiders
Held by institutions
Institutions holding
Free account required

Price targets, consensus spread, insider and institutional ownership.

Moving averages & technicals

Computed from 2Y daily closes
SMA 10
550.00
0.00% from price
SMA 20
564.50
-2.57% from price
SMA 50
601.18
-8.51% from price
SMA 100
722.49
-23.87% from price
SMA 200
848.95
-35.21% from price
EMA 12
554.67
-0.84% from price
EMA 26
572.00
-3.85% from price
EMA 50
612.42
-10.19% from price
RSI (14)
44.5
Neutral
MACD (12,26,9)
-17.33
Hist 2.30
ATR (14)
2.71
0.49% of price
Realised vol 30D
114.2%
Annualised
Bollinger upper
618.06
20, 2σ
Bollinger lower
510.94
20, 2σ
50 / 200 cross
Death
601.18 vs 848.95
Trend bias
Below 200
-35.21%

Options chain

Account required
Expiry
Spot 550.00
Calls
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Puts
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Risk profile

Daily returns · 1Y window
Beta vs SPY
-0.08
Less volatile than market
Correlation to SPY
-0.01
Largely independent
Realised vol 30D
114.2%
Annualised
Market vol 1Y
12.8%
SPY, annualised
Max drawdown 1Y
-60.2%
Peak to trough
Max drawdown 5Y
-88.8%
Peak to trough
ATR 14
2.71
0.49% of price
Beta (reported)
5Y monthly, from filing

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.